tradit
drug
discoveri
start
experiment
screen
chemic
librari
find
hit
compound
bind
protein
target
modul
activ
subsequ
round
iter
chemic
derivit
rescreen
conduct
enhanc
potenc
select
pharmacolog
properti
hit
compound
although
comput
dock
ligand
target
use
augment
empir
discoveri
process
histor
effect
limit
poor
correl
ligand
dock
score
experiment
determin
bind
constant
recent
progress
supercomput
coupl
theoret
insight
allow
calcul
gibb
free
energi
therefor
accur
bind
constant
usual
larg
ligandreceptor
system
advanc
extend
potenti
virtual
drug
discoveri
specif
embodi
technolog
integr
de
novo
abstract
fragment
base
drug
design
sophist
molecular
simul
abil
calcul
thermodynam
bind
constant
unpreced
accuraci
discuss
drug
discoveri
distress
number
approv
new
molecular
entiti
declin
steadili
year
cost
per
new
approv
compound
breach
one
billion
unit
state
dollar
usd
benchmark
one
inform
estim
financi
return
provid
therapeut
product
categori
even
recov
capit
cost
develop
moreov
biolog
remov
model
net
present
valu
pharmaceut
research
develop
r
invest
actual
neg
disturbingli
poor
research
perform
occur
context
increas
social
need
rise
incid
drug
resist
bacteria
well
document
viral
pathogen
sever
acut
respiratori
syndrom
sar
dengu
pose
pandem
threat
age
affluent
global
popul
drive
preval
chronic
diseas
anyth
difficult
infecti
diseas
drug
unit
state
censu
bureau
project
male
femal
year
old
older
rate
cancer
expect
rise
diabet
cardiovascular
complaint
mental
disord
total
increas
chronic
morbid
us
popul
increas
success
drug
discoveri
especi
difficult
chronic
target
clearli
desir
howev
progress
must
materi
framework
reduc
per
compound
cost
enhanc
effici
sinc
capit
continu
flow
sector
offer
net
neg
return
comput
virtual
drug
discoveri
strategi
potenti
cheaper
faster
offer
attract
altern
least
complimentari
rout
improv
r
perform
therapeut
sector
physiolog
effect
drug
mediat
electrostat
geometr
interact
atom
ligand
atom
correspond
receptor
interact
conform
law
physic
quantum
chemistri
therefor
describ
predict
mathemat
model
although
model
complex
quantum
case
inher
nonexact
research
activ
comput
intens
field
molecular
graphic
realiz
thirti
year
ago
silico
assess
drugreceptor
bind
could
deploy
acceler
drug
discoveri
also
realiz
continu
oper
moor
law
month
doubl
comput
effici
economi
impli
ongo
improv
refin
comput
techniqu
crux
comput
drug
discoveri
paradigm
coupl
fundament
law
biophys
acceler
technolog
perform
semiconductor
industri
former
inspir
faith
approach
work
theori
latter
work
practic
virtual
screen
whether
compound
molecular
fragment
two
stage
first
algorithm
attempt
find
correct
conform
posit
ligand
activ
site
receptor
tri
quantifi
qualiti
particular
atom
arrang
assign
score
sever
technic
differ
approach
predict
ligandreceptor
interact
develop
known
dock
algorithm
suggest
name
primogenitor
program
dock
model
ligandreceptor
atom
interact
presuppos
accur
threedimension
molecular
structur
receptor
interatom
forc
calcul
sinc
protein
fold
yet
model
mean
xray
crystal
nmr
structur
receptor
homolog
model
map
relat
protein
sequenc
onto
known
structur
priori
one
might
suppos
experiment
determin
crystal
structur
inevit
superior
surprisingli
metaanalysi
dock
studi
conclud
case
virtual
screen
success
homolog
model
compar
experiment
structur
seem
counterintuit
may
indic
relax
precis
homolog
model
indirectli
captur
conform
flexibl
lost
frozen
possibl
subtli
distort
crystal
structur
case
homolog
model
must
start
close
relat
experiment
structur
import
contribut
factor
increas
util
comput
drug
discoveri
rapid
growth
number
avail
protein
structur
current
approach
structur
protein
data
base
http
wwwpdborgpdb
statisticscontentgrowthchartdo
contenttot
seqid
number
turn
reflect
improv
protein
product
robot
crystal
regimen
wide
avail
sophist
advanc
light
sourc
anoth
posit
develop
virtual
screen
infrastructur
creation
curat
virtual
compound
databas
provid
larg
prebuilt
set
virtual
represent
commerci
avail
molecul
suitabl
input
virtual
screen
zinc
univers
california
san
francisco
eduliss
edinburgh
univers
two
exampl
much
larger
chemic
univers
databas
take
differ
approach
attempt
construct
univers
synthet
plausibl
rather
avail
compound
high
level
perform
dock
program
measur
two
criteria
dock
power
abil
identifi
correct
experiment
ligand
bind
pose
collect
incorrect
comput
gener
decoy
pose
ie
abil
correctli
posit
ligand
activ
site
pose
score
power
abil
produc
dock
bind
score
correl
experiment
determin
bind
affin
past
decad
larg
number
compar
studi
perform
variou
dock
program
undertaken
academ
pharmaceut
set
despit
divers
background
investig
although
studi
differ
methodolog
directli
compar
nevertheless
unanim
agre
two
point
one
dock
algorithm
fairli
accur
pose
ligand
activ
site
two
dock
algorithm
poorli
score
ligand
affin
word
dock
program
correctli
identifi
geometri
ligandreceptor
system
gener
accur
predict
bind
energi
therefor
predict
ligand
potenc
make
concret
typic
dock
screen
might
produc
hit
compound
potent
compound
like
rank
bottom
list
score
function
appear
near
top
signific
defici
sinc
expect
potenc
compound
often
oper
featur
interest
exampl
priorit
compound
medicin
chemistri
sum
dock
algorithm
pose
ligand
well
score
poorli
beyond
dock
score
accur
bind
affin
thermodynam
calcul
mapl
cafe
dg
rt
ln
k
exactli
relat
comput
gibb
free
energi
differ
dg
experiment
measur
dissoci
constant
k
temperatur
r
ga
constant
free
energi
differ
bound
unbound
equilibrium
state
proteinligandwat
system
dg
give
bind
affin
ligand
gener
translat
drug
efficaci
word
correct
comput
dg
valu
seri
ligand
lead
immedi
ligand
list
accur
rank
potenc
comput
method
perform
dg
calcul
studi
enthusiast
sinc
late
prove
nonequilibrium
process
finitetim
deriv
bind
free
energi
exactli
theoret
insight
follow
dg
shown
approach
massiv
parallel
comput
scale
thousand
concurr
cpu
reduc
comput
requir
year
day
allow
bind
free
energi
real
molecular
system
comput
access
high
perform
comput
resourc
made
possibl
import
seri
proof
concept
experi
turn
produc
calcul
bind
affin
excel
agreement
correspond
experiment
valu
subsequ
comput
methodolog
improv
better
forc
field
refin
method
implement
platform
christen
massiv
parallel
comput
absolut
bind
free
energi
well
equilibr
system
mapl
cafe
valid
followon
project
use
thermodynam
calcul
come
heavi
comput
burden
exampl
tradeoff
speed
accuraci
turn
mani
comput
problem
recent
advanc
construct
largescal
comput
environ
shrunk
envelop
comput
time
brought
method
realm
practic
applic
http
wwwnscrikenjpindexenghtml
http
cumul
improv
comput
methodolog
enhanc
infrastructur
theoret
advanc
combin
achiev
chemic
thermodynam
calcul
suffici
accur
provid
reliabl
order
priorit
list
hit
compound
either
virtual
librari
de
novo
design
three
separ
organ
compar
bind
affin
predict
method
defin
data
set
use
ident
forc
field
paramet
show
correl
observ
bind
affin
comput
bind
free
energi
four
method
comput
time
requir
method
conform
expect
comput
method
produc
result
correl
somewhat
experiment
valu
signific
differ
scale
shift
origin
vertic
axi
mapl
cafe
produc
best
agreement
differ
observ
affin
within
kcalmol
error
kcalmol
good
benchmark
comput
accuraci
sinc
error
experiment
measur
affin
rang
virtual
drug
discoveri
mitchel
matsumoto
setup
molecular
model
protein
ligand
water
assign
forc
field
paramet
equilibr
system
intial
pose
molecular
dynam
run
comput
nonequilibrum
work
term
bound
unbound
equilibrium
state
estim
like
repres
bind
free
energi
micro
state
sum
micro
bind
free
ene
rgi
get
total
bind
free
energi
opmf
mapl
cafe
workflow
standard
drugdesign
process
opmf
compris
five
step
search
energet
stabl
posit
abstract
fragment
inon
target
protein
molecular
mechan
simul
mm
discret
investig
physic
discov
molecular
fragment
exampl
nmr
crystal
soak
substitut
virtual
fragment
input
b
select
stabli
posit
set
mapl
caff
challeng
pharmaceut
industri
collabor
blindtest
bind
affin
predict
unpublish
result
algorithm
given
structur
cancer
relat
protein
five
ligand
one
cocryst
structur
three
without
cocryst
data
small
molecul
similar
first
final
ligand
without
cocryst
data
structur
dissimilar
other
experiment
determin
bind
affin
hidden
seen
figur
result
show
good
agreement
bind
free
energi
comput
mapl
cafe
experiment
measur
dissoci
constant
one
outlier
howev
pharmaceut
partner
suggest
particular
experiment
measur
unreli
inde
repeat
experiment
valu
fell
within
kcalmol
comput
valu
coher
structur
base
drugdesign
platform
mapl
cafe
part
larger
structur
simul
base
drugdesign
ssbdd
platform
figur
also
includ
optimum
pack
molecular
fragment
opmf
modul
abstract
fragment
base
de
novo
drugdesign
tool
figur
compon
ssbdd
appli
specif
purpos
independ
platform
design
integr
system
creat
novel
activ
chemic
entiti
opmf
virtual
fragment
base
de
novo
drugdesign
tool
gener
chemic
structur
predict
bind
modul
activ
target
protein
whose
structur
known
order
examin
vast
virtual
chemic
space
effici
opmf
gener
realatom
fragment
abstract
conceptu
fragment
first
step
strategi
allow
small
number
abstract
fragment
repres
thousand
real
fragment
exampl
benzen
pyridin
pyrimidin
triazin
gener
abstract
sixmemb
aromat
ring
built
abstract
atom
repres
diamet
properti
approxim
revers
later
abstract
structur
replac
precis
assign
realatom
rigor
captur
exact
physic
featur
includ
electrostat
orbit
van
der
waal
radii
mapl
cafe
bind
affin
predict
system
alreadi
mention
comput
dg
precis
possibl
use
massiv
parallel
sampl
method
reinforc
mani
molecular
dynam
md
simul
figur
parallel
via
messag
pass
interfac
mpi
play
critic
role
system
equilibr
step
mapl
cafe
figur
exampl
allow
inform
hydrogen
bond
frequenc
deriv
fed
back
drugdesign
process
comput
nonequilibrium
work
term
figur
invok
numer
md
job
made
practic
adopt
massiv
parallel
approach
md
job
gener
take
coupl
day
singl
cpu
core
mpi
parallel
microst
md
job
would
reduc
comput
time
almost
proport
number
core
therefor
cpu
core
avail
would
possibl
examin
hundr
novel
structur
week
without
actual
synthesi
biggest
advantag
silico
technolog
altern
gener
parallel
commod
cluster
recent
shown
special
purpos
built
comput
architectur
acceler
md
calcul
two
order
magnitud
integr
ssbdd
platform
built
creat
activ
novel
chemic
structur
chemic
synthesi
novel
featur
platform
abil
calcul
ligand
affin
constant
great
accuraci
despit
substanti
comput
resourc
requir
achiev
accuraci
approach
cost
effect
dramat
reduc
time
expens
associ
unnecessari
experiment
synthesi
assay
enabl
chemist
focu
synthet
effort
chemic
structur
like
lead
therapeut
success
current
bind
affin
predict
mapl
cafe
tend
unstabl
actual
affin
weak
ligand
proton
improv
sampl
algorithm
weak
bind
state
charg
correct
method
proton
also
reduc
requisit
cpu
resourc
much
possibl
without
sacrif
accuraci
avail
next
gener
supercomput
put
practic
thermodynam
guid
drugdesign
platform
virtual
drug
discoveri
mitchel
matsumoto
figur
legend
continu
abstract
fragment
follow
drugdesign
strategi
c
exhaust
connect
select
fragment
constraint
gener
mani
abstract
molecular
skeleton
possibl
stabil
mm
assign
possibl
realatom
abstract
skeleton
consid
biophys
constraint
synthet
feasibl
e
screen
unfavor
structur
use
heurist
occurr
pharmacophor
rais
toxicolog
red
flag
standard
mapl
cafe
workflow
compris
five
step
f
j
f
setup
molecular
model
protein
ligand
water
assign
forc
field
paramet
forc
field
formul
organ
molecul
fffom
cocryst
avail
reason
initi
bide
pose
obtain
dock
method
notabl
realist
molecular
model
refin
forc
field
paramet
essenti
well
effici
algorithm
reliabl
comput
method
estim
g
equilibr
system
initi
pose
md
job
h
comput
nonequilibrium
work
term
bound
unbound
equilibrium
state
actual
two
end
state
divid
microst
decoupl
paramet
trajectori
microst
comput
md
job
estim
like
repres
bind
free
energi
microst
bar
bennett
accept
ratio
statist
method
j
final
sum
micro
bind
free
energi
get
total
bind
free
energi
molecul
submit
mapl
cafe
free
energi
calcul
sourc
exampl
might
origin
propos
molecul
medicin
chemistri
seri
k
dock
type
virtual
screen
l
accur
swift
within
reach
move
forward
acceler
comput
virtual
drug
discoveri
platform
support
bolster
success
therapeut
r
outcom
contribut
better
human
health
